Package 71335-0801-2

{"route": ["ORAL"], "spl_id": "645edeba-9a73-4d0a-ac84-2de98e89b760", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993536"], "spl_set_id": ["7ded4fa6-e637-4d59-a1b1-286854d4fe3a"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-1)", "package_ndc": "71335-0801-1", "marketing_start_date": "20180501"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-2)", "package_ndc": "71335-0801-2", "marketing_start_date": "20240809"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-3)", "package_ndc": "71335-0801-3", "marketing_start_date": "20240809"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-4)", "package_ndc": "71335-0801-4", "marketing_start_date": "20240809"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-5)", "package_ndc": "71335-0801-5", "marketing_start_date": "20240809"}, {"sample": false, "description": "28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0801-6)", "package_ndc": "71335-0801-6", "marketing_start_date": "20240809"}], "brand_name": "bupropion", "product_id": "71335-0801_645edeba-9a73-4d0a-ac84-2de98e89b760", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71335-0801", "generic_name": "bupropion hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "200 mg/1"}], "application_number": "ANDA202304", "marketing_category": "ANDA", "marketing_start_date": "20141101", "listing_expiration_date": "20261231"}